GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Revenue per Share

Biohit Oyj (OHEL:BIOBV) Revenue per Share : €0.86 (TTM As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Revenue per Share?

Biohit Oyj's revenue per share for the six months ended in Dec. 2023 was €0.43. Biohit Oyj's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.86.

During the past 12 months, the average Revenue Per Share Growth Rate of Biohit Oyj was 18.80% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 22.20% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 5.50% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Biohit Oyj's Revenue per Share or its related term are showing as below:

OHEL:BIOBV' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -62   Med: 7   Max: 40
Current: 22.2

During the past 13 years, Biohit Oyj's highest 3-Year average Revenue Per Share Growth Rate was 40.00% per year. The lowest was -62.00% per year. And the median was 7.00% per year.

OHEL:BIOBV's 3-Year Revenue Growth Rate is ranked better than
73.14% of 778 companies
in the Biotechnology industry
Industry Median: 3.6 vs OHEL:BIOBV: 22.20

Biohit Oyj Revenue per Share Historical Data

The historical data trend for Biohit Oyj's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Revenue per Share Chart

Biohit Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.47 0.62 0.73 0.86

Biohit Oyj Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.41 0.32 0.43 0.43

Competitive Comparison of Biohit Oyj's Revenue per Share

For the Biotechnology subindustry, Biohit Oyj's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biohit Oyj's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's PS Ratio distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's PS Ratio falls into.



Biohit Oyj Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Biohit Oyj's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=13.076/15.127
=0.86

Biohit Oyj's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=6.576/15.174
=0.43

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj  (OHEL:BIOBV) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Biohit Oyj Revenue per Share Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines